Literature DB >> 18323789

Critical role of HIF-1alpha in keratinocyte defense against bacterial infection.

Carole Peyssonnaux1, Adam T Boutin, Annelies S Zinkernagel, Vivekanand Datta, Victor Nizet, Randall S Johnson.   

Abstract

Skin, the first barrier against invading microorganisms, is hypoxic, even under baseline conditions. The transcription factor hypoxia-inducible factor-1alpha (HIF-1alpha, the principal regulator of cellular adaptation to low oxygen, is strongly expressed in skin epithelium. HIF-1alpha is now understood to play a key role in the bactericidal capacity of phagocytic cells such as macrophages and neutrophils. In the skin, keratinocytes provide a direct antibacterial activity through production of antimicrobial peptides, including cathelicidin. Here, we generate mice with a keratinocyte-specific deletion of HIF-1alpha and examine effects on intrinsic skin immunity. Keratinocyte HIF-1alpha is seen to provide protection against necrotic skin lesions produced by the pathogen group A Streptococcus. RNA interference studies reveal that HIF-1alpha regulation of keratinocyte cathelicidin production is critical to their antibacterial function.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18323789     DOI: 10.1038/jid.2008.27

Source DB:  PubMed          Journal:  J Invest Dermatol        ISSN: 0022-202X            Impact factor:   8.551


  56 in total

Review 1.  Interactions between nitric oxide and hypoxia-inducible factor signaling pathways in inflammatory disease.

Authors:  Nels Olson; Albert van der Vliet
Journal:  Nitric Oxide       Date:  2011-01-01       Impact factor: 4.427

Review 2.  Interplay between Candida albicans and the antimicrobial peptide armory.

Authors:  Marc Swidergall; Joachim F Ernst
Journal:  Eukaryot Cell       Date:  2014-06-20

Review 3.  Neutrophils and inflammatory metabolism in antimicrobial functions of the mucosa.

Authors:  Eric L Campbell; Sean P Colgan
Journal:  J Leukoc Biol       Date:  2015-02-24       Impact factor: 4.962

4.  MicroRNAs and their target genes in gingival tissues.

Authors:  C Stoecklin-Wasmer; P Guarnieri; R Celenti; R T Demmer; M Kebschull; P N Papapanou
Journal:  J Dent Res       Date:  2012-08-09       Impact factor: 6.116

5.  A new pharmacological agent (AKB-4924) stabilizes hypoxia inducible factor-1 (HIF-1) and increases skin innate defenses against bacterial infection.

Authors:  Cheryl Y M Okumura; Andrew Hollands; Dan N Tran; Joshua Olson; Samira Dahesh; Maren von Köckritz-Blickwede; Wdee Thienphrapa; Courtney Corle; Seung Nam Jeung; Anna Kotsakis; Robert A Shalwitz; Randall S Johnson; Victor Nizet
Journal:  J Mol Med (Berl)       Date:  2012-02-28       Impact factor: 4.599

6.  Hypoxia in Leishmania major skin lesions impairs the NO-dependent leishmanicidal activity of macrophages.

Authors:  Alexander Mahnke; Robert J Meier; Valentin Schatz; Julian Hofmann; Kirstin Castiglione; Ulrike Schleicher; Otto S Wolfbeis; Christian Bogdan; Jonathan Jantsch
Journal:  J Invest Dermatol       Date:  2014-02-28       Impact factor: 8.551

7.  Augmentation of Urinary Lactoferrin Enhances Host Innate Immune Clearance of Uropathogenic Escherichia coli.

Authors:  Kathryn A Patras; Albert D Ha; Emma Rooholfada; Joshua Olson; Satish P Ramachandra Rao; Ann E Lin; Victor Nizet
Journal:  J Innate Immun       Date:  2019-05-03       Impact factor: 7.349

8.  Hypoxia promotes Mycobacterium tuberculosis-specific up-regulation of granulysin in human T cells.

Authors:  Sebastian F Zenk; Michael Vollmer; Esra Schercher; Stephanie Kallert; Jan Kubis; Steffen Stenger
Journal:  Med Microbiol Immunol       Date:  2015-11-27       Impact factor: 3.402

Review 9.  Hypoxia-dependent regulation of inflammatory pathways in immune cells.

Authors:  Cormac T Taylor; Glen Doherty; Padraic G Fallon; Eoin P Cummins
Journal:  J Clin Invest       Date:  2016-07-25       Impact factor: 14.808

10.  Self-RNA-antimicrobial peptide complexes activate human dendritic cells through TLR7 and TLR8.

Authors:  Dipyaman Ganguly; Georgios Chamilos; Roberto Lande; Josh Gregorio; Stephan Meller; Valeria Facchinetti; Bernhard Homey; Franck J Barrat; Tomasz Zal; Michel Gilliet
Journal:  J Exp Med       Date:  2009-08-24       Impact factor: 14.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.